Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.355
-0.115 (-7.82%)
Mar 31, 2025, 1:13 PM EDT - Market open
PLRX's stock price has decreased by -89.9% in the past year and price targets may not have had time to catch up.
Pliant Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Hold
Price Target
$9.79
Upside
+622.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 4, 2025 |
| Citigroup | Citigroup | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +10.70% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +121.40% | Mar 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Mar 4, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +121.40% | Mar 4, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades $10 | Strong Buy → Hold | Downgrades | $10 | +638.01% | Mar 4, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $33 → $2 | Buy → Hold | Downgrades | $33 → $2 | +47.60% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +638.01% | Feb 14, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $45 → $4 | Buy → Hold | Downgrades | $45 → $4 | +195.20% | Feb 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $4 | Strong Buy → Hold | Downgrades | $4 | +195.20% | Feb 10, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $41 → $4 | Buy → Hold | Downgrades | $41 → $4 | +195.20% | Feb 10, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $44 → $4 | Strong Buy → Hold | Downgrades | $44 → $4 | +195.20% | Feb 10, 2025 |
| Needham | Needham | Strong Buy Maintains $38 → $10 | Strong Buy | Maintains | $38 → $10 | +638.01% | Feb 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.